Nature Communications, 2024 A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes Halama A., Zaghlool S., Thareja G. et al. Olink Target 96Metabolic DiseasesWider Bioinformatics StudiesPathophysiologyPlasma | | | | |
Clinical Cancer Bulletin, 2024 Causal associations of plasma proteins with lung squamous cell carcinoma risk: a proteome-wide Mendelian randomization and colocalization analysis Wang Q., Xue X., Ling X. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Journal of Bone and Mineral Metabolism, 2024 Olink and gut microbial metabolomics reveal new biomarkers for the prediction and diagnosis of PMOP Wu R., Wu J., Jin H. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma | | | | |
Journal of Neuroinflammation, 2024 The differential proteomic response to ischemic stroke in appalachian subjects treated with mechanical thrombectomy McLouth C., Maglinger B., Frank J. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Journal of Proteome Research, 2024 Using Data-Driven Algorithms with Large-Scale Plasma Proteomic Data to Discover Novel Biomarkers for Diagnosing Depression Ma S., Li R., Gong Q. et al. Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationData SciencePlasma | | | | |
Frontiers in Pharmacology, 2024 Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization Yuan W., Li J., Gao S. et al. Olink Explore 3072/384OphthalmologyPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2024 Causal association between circulating inflammatory proteins and peripheral artery disease: a bidirectional two-sample Mendelian randomization study Zhao J., Sun B., Huang S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Frontiers in Cardiovascular Medicine, 2024 Clinical characteristics and biomarkers feature analysis using a proteomics platform in young patients with acute coronary syndrome Zhang K., Wang F., Yu Q. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
JACC: Basic to Translational Science, 2024 Proteomic Profile of the ICAM1 p.K56M HFpEF Risk Variant Giro P., Filipp M., Zhang M. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Science Translational Medicine, 2024 Natural killer cells promote neutrophil extracellular traps and restrain macular degeneration in mice Dong X., Song Y., Liu Y. et al. Olink Target 96 MouseOphthalmologyPathophysiologyAqueous Humor | | | | |
Respiratory Research, 2024 Integrated omics characterization reveals reduced cancer indicators and elevated inflammatory factors after thermal ablation in non-small cell lung cancer patients Zhang X., Shao S., Song N. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2024 Immunological characterization of IgG subclass deficiency reveals decreased Tregs and increased circulating costimulatory and regulatory immune checkpoints Wågström P., Hjorth M., Appelgren D. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
American Journal of Transplantation, 2024 Trained immunity suppression determines kidney allograft survival Jonkman I., Jacobs M., Negishi Y. et al. Olink Target 96NephrologyPathophysiologySerum | | | | |
Archives of Dermatological Research, 2024 Exploring novel drug targets for atopic dermatitis through plasma proteome with genome Wu W., Su H., Chen Z. et al. Olink Explore 3072/384Inflammatory;PathophysiologyPlasma | | | | |
Gut, 2024 External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn’s disease stopping infliximab Pierre N., Huynh-Thu V., Baiwir D. et al. Olink Target 96Olink Target 48Immunological & Inflammatory DiseasesPatient Stratification | | | | |
Clinical and Experimental Hypertension, 2024 Causal relationship between gut microbiota, plasma metabolites, inflammatory cytokines and abdominal aortic aneurysm: a Mendelian randomization study Li C., Liu Z., Yang S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Immunity, 2024 Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics Raeber M., Caspar D., Zurbuchen Y. et al. Olink Target 96Immunological & Inflammatory DiseasesImmunotherapyPathophysiologySerum | | | | |
Alzheimer's & Dementia, 2024 Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age Charisis S., Short M., Bernal R. et al. Olink Explore 3072/384NeurologyPathophysiologySerum | | | | |
Alzheimer's & Dementia, 2024 Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration Duggan M., Yang Z., Cui Y. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
Journal of Proteome Research, 2024 Plasma Olink Proteomics Reveals Novel Biomarkers for Prediction and Diagnosis in Dilated Cardiomyopathy with Heart Failure Xu S., Zhang G., Tan X. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |